Biotechnology

Samsung Biologics named Champion in 2020 CMO Leadership Awards

SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it has been awarded the 2020 CMO Leadership Awards for its excellence in the Capabilities, Compatibility, Quality, Reliability, and Service categories across Big Pharma and Overall (combined Big and Sm...

2020-04-08 20:00 315

THE.WAVE.TALK raises US$2M

SEOUL, South Korea, April 7, 2020 /PRNewswire/ -- THE.WAVE.TALK, a member company of theBorn2Global Centre, successfully attracted a funding of USD 2 million in early February from Yellowdog and Silicon Valley-based Big Basin Capital, bringing its accumulated total to approximately USD 6 million ...

2020-04-07 20:30 378

Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment

SONGDO, South Korea, April 5, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovascular disorders. Under th...

2020-04-06 08:00 372

Gracell Announces China NMPA Acceptance of Investigational New Drug Application for GC007g Cell Therapy for CD19 Positive Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

SHANGHAI and SUZHOU, China, April 3, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell & gene therapy company, is pleased to announce that China National Medical Products Administration (NMPA) has accepted Gracell's Investigational New Drug (IND) ...

2020-04-03 22:00 873

ImmuneMed's 'hzVSF,' Used for Treatment of COVID-19 Pneumonia Patients

CHUNCHEON, South Korea, March 30, 2020 /PRNewswire/ -- 'hzVSF v13 (humanized Virus Suppressing Factor; VSF)', a treatment that can be used for a wide range of viral diseases developed by ImmuneMed, was administered onMarch 28th at Yonsei University Hospital to treat COVID-19 pneumonia patients...

2020-03-30 21:00 482

Samsung Biologics expands leadership for CDO business

SONGDO, South Korea, March 30, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) has appointedEun Young Yang as vice president of business development for the company's expanded CDO (contract development organization) business.

2020-03-30 21:00 497

WuXi Biologics Achieved Remarkable Results in 2019

57.2% Revenue Growth to RMB3,983.7 Million 63.0% Gross Profit Growth to RMB1,658.8 Million Adjusted Net Profit Up 60.3% to RMB1,205.0 Million Diluted EPS of RMB0.76 and Adjusted Diluted EPS of RMB0.91, Increasing 58.3% and 59.6% Backlog Increased 40.2% to US$5.1 Billion Milestone Payments Surg...

2020-03-26 21:32 4558

WuXi AppTec Reports Strong 2019 Annual Results

Revenue Growth Accelerated 33.9% Year-Over-Year to RMB12,872 Million Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 38.2% Year-Over-Year toRMB2,407 Million Adjusted Diluted Non-IFRS EPS Up by 19.7% to RMB1.46[1] SHANGHAI, March 24, 2020 /PRNewswire/ -- WuXi AppTec Co., Ltd. ...

2020-03-24 18:56 5407

Novogene unveils intelligent Next Generation Sequencing delivery platform - Falcon

BEIJING, March 24, 2020 /PRNewswire/ -- Novogene recently announced Falcon, the first intelligent delivery platform for high-throughput Next Generation Sequencing (NGS). This platform represents a breakthrough in traditional NGS and will shape NGS industry standards and drive the future developme...

2020-03-24 17:07 582

Samsung Biologics Adds Greater Expertise and Diversity to Its Board

SONGDO, South Korea, March 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced the appointment and expansion of its board of directors at its 9th annual general meeting of shareholders that took place on March 20th . In the course of expanding its business model from a contract manufa...

2020-03-20 20:00 1604

Glucagon Receptor Structures Reveal G protein Specificity Mechanism

SHANGHAI, March 19, 2020 /PRNewswire/ -- Recently, scientists at Shanghai Institute ofMateria Medica (SIMM) of Chinese Academy of Sciences, together with scientists at Institute of Biophysics (IBP) of Chinese Academy of Sciences and Monash University, determined two cryo-electron microscopy (cryo...

2020-03-20 02:00 882

West China Hospital in Chengdu Donates COVID-19 Test Kits to Georgia

CHENGDU, China, March 16, 2020 /PRNewswire/ -- On March 12, the West China Hospital affiliated toSichuan University donated a batch of isothermal nucleic acid amplification microfluidic chip analyzers and nucleic acid test kits, which can detect and distinguish six respiratory viruses, including ...

2020-03-17 11:12 573

EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells

EDV™ Technology Stimulates Both Innate and Adaptive Immune Response and Confers Long-Term Survival Research Paves Way for Treatment of Drug-Resistant, End-Stage Cancers NEW YORK and SYDNEY, March 17, 2020 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its ...

2020-03-17 00:35 1093

Huami Corporation Reports Fourth Quarter and Full Year 2019 Unaudited Financial Results

BEIJING, March 13, 2020 /PRNewswire/ -- Huami Corporation ("Huami" or the "Company") (NYSE: HMI), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced its unaudited financial results for the fourth quarter and full year endedDecember 31, 2019. ...

2020-03-13 18:00 9286

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019

BEIJING, March 12, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its financial results for the fourth quarter and fiscal year of 2019. Fourt...

2020-03-13 05:00 9299

WuXi AppTec Wuhan Site Resumes Operation

SHANGHAI, March 11, 2020 /PRNewswire/ -- WuXi AppTec announced today that the company'sWuhan site has resumed operations, in compliance with local regulations and global COVID-19 health and safety guidelines. Operations at the Wuhan facility, which provides discovery chemistry services, will ramp ...

2020-03-11 20:00 491

Concord Medical Welcomes RMB700 Million Investment

BEIJING, March 11, 2020 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research, education and prevention by operating a network of medically advanced comprehensive cancer hospitals and...

2020-03-11 15:40 4431

Happiness Biotech Reports Monthly Online Sales Growth of 694%

NANPING, China, March 9, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's monthly online sales have reached historical high ofRMB11.5 million (approxima...

2020-03-09 20:00 6977

China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results

BEIJING, March 3, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its fourth quarter and fiscal year 2019 fi...

2020-03-03 21:30 6830

Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug

SONGDO, South Korea, March 2, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will offer a wide range of services from c...

2020-03-03 03:00 499
12345 ... 99